Diphthamide-deficiency syndrome: a novel human developmental disorder and ribosomopathy

[1]  S. Baserga,et al.  Ribosomopathies: Old Concepts, New Controversies. , 2019, Trends in genetics : TIG.

[2]  J. Freed,et al.  The asymmetric function of Dph1–Dph2 heterodimer in diphthamide biosynthesis , 2019, JBIC Journal of Biological Inorganic Chemistry.

[3]  Rajesh Poothrikovil,et al.  Nonketotic Hyperglycinemia: Two Case Reports and Review , 2019, The Neurodiagnostic journal.

[4]  Médecine,et al.  Diamond-Blackfan Anemia , 2019, Clinical Disorders and Experimental Models of Erythropoietic Failure.

[5]  U. Brinkmann,et al.  DPH1 syndrome: two novel variants and structural and functional analyses of seven missense variants identified in syndromic patients , 2019, European Journal of Human Genetics.

[6]  S. Glatt,et al.  Roles of Elongator Dependent tRNA Modification Pathways in Neurodegeneration and Cancer , 2018, Genes.

[7]  B. Shin,et al.  MEHMO syndrome mutation EIF2S3-I259M impairs initiator Met-tRNAiMet binding to eukaryotic translation initiation factor eIF2 , 2018, Nucleic acids research.

[8]  V. Bezzerri,et al.  Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives , 2018, Molecular Diagnosis & Therapy.

[9]  U. Brinkmann,et al.  Importance of diphthamide modified EF2 for translational accuracy and competitive cell growth in yeast , 2018, PloS one.

[10]  I. Pastan,et al.  Diphthamide affects selenoprotein expression: Diphthamide deficiency reduces selenocysteine incorporation, decreases selenite sensitivity and pre-disposes to oxidative stress , 2018, Redox biology.

[11]  I. Pastan,et al.  Interplay between reversible phosphorylation and irreversible ADP-ribosylation of eukaryotic translation elongation factor 2 , 2018, Biological chemistry.

[12]  M. Miura,et al.  The hidden nature of protein translational control by diphthamide: the secrets under the leather. , 2018, Journal of biochemistry.

[13]  M. Yusupov,et al.  Structural Insights into the Role of Diphthamide on Elongation Factor 2 in mRNA Reading-Frame Maintenance. , 2018, Journal of molecular biology.

[14]  L. Nguyen,et al.  Elongator subunit 3 (ELP3) modifies ALS through tRNA modification , 2018, Human molecular genetics.

[15]  U. Brinkmann,et al.  Disruption of diphthamide synthesis genes and resulting toxin resistance as a robust technology for quantifying and optimizing CRISPR/Cas9-mediated gene editing , 2017, Scientific Reports.

[16]  P. Blackburn,et al.  Maple syrup urine disease: mechanisms and management , 2017, The application of clinical genetics.

[17]  U. Brinkmann,et al.  Influence of DPH1 and DPH5 Protein Variants on the Synthesis of Diphthamide, the Target of ADP-Ribosylating Toxins , 2017, Toxins.

[18]  S. Antonarakis,et al.  Exome sequencing discloses KALRN homozygous variant as likely cause of intellectual disability and short stature in a consanguineous pedigree , 2016, Human Genomics.

[19]  S. Ferdinandusse,et al.  Human disorders of peroxisome metabolism and biogenesis. , 2016, Biochimica et biophysica acta.

[20]  Wen J. Li,et al.  Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation , 2015, Nucleic Acids Res..

[21]  James Y. Zou Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[22]  I. Pastan,et al.  Loss of diphthamide pre-activates NF-κB and death receptor pathways and renders MCF7 cells hypersensitive to tumor necrosis factor , 2015, Proceedings of the National Academy of Sciences.

[23]  A. Fatemi,et al.  ELP2 is a novel gene implicated in neurodevelopmental disabilities , 2015, American journal of medical genetics. Part A.

[24]  Michael J E Sternberg,et al.  The Phyre2 web portal for protein modeling, prediction and analysis , 2015, Nature Protocols.

[25]  M. Stark,et al.  The diphthamide modification pathway from Saccharomyces cerevisiae – revisited , 2014, Molecular microbiology.

[26]  A. Byström,et al.  Familial dysautonomia (FD) patients have reduced levels of the modified wobble nucleoside mcm(5)s(2)U in tRNA. , 2014, Biochemical and biophysical research communications.

[27]  Chun-Ming Chen,et al.  Role of OVCA1/DPH1 in craniofacial abnormalities of Miller-Dieker syndrome. , 2014, Human molecular genetics.

[28]  Hening Lin,et al.  Dph7 Catalyzes a Previously Unknown Demethylation Step in Diphthamide Biosynthesis , 2014, Journal of the American Chemical Society.

[29]  J. Freed,et al.  Dph3 Is an Electron Donor for Dph1-Dph2 in the First Step of Eukaryotic Diphthamide Biosynthesis , 2014, Journal of the American Chemical Society.

[30]  J. Lethor,et al.  Cardiomyopathies and congenital heart diseases in Shwachman-Diamond syndrome: a national survey. , 2013, International journal of cardiology.

[31]  M. Stark,et al.  Insights into Diphthamide, Key Diphtheria Toxin Effector , 2013, Toxins.

[32]  I. Pastan,et al.  A Modified Form of Diphthamide Causes Immunotoxin Resistance in a Lymphoma Cell Line with a Deletion of the WDR85 Gene* , 2013, The Journal of Biological Chemistry.

[33]  F. Giorgini,et al.  The Amidation Step of Diphthamide Biosynthesis in Yeast Requires DPH6, a Gene Identified through Mining the DPH1-DPH5 Interaction Network , 2013, PLoS genetics.

[34]  S. Leppla,et al.  Diphthamide modification on eukaryotic elongation factor 2 is needed to assure fidelity of mRNA translation and mouse development , 2012, Proceedings of the National Academy of Sciences.

[35]  A. Davies,et al.  Regulation of neural process growth, elaboration and structural plasticity by NF-κB , 2011, Trends in Neurosciences.

[36]  M. Caruso,et al.  A Dominant-Negative Approach That Prevents Diphthamide Formation Confers Resistance to Pseudomonas Exotoxin A and Diphtheria Toxin , 2010, PloS one.

[37]  Hening Lin,et al.  Diphthamide biosynthesis requires an organic radical generated by an iron–sulphur enzyme , 2010, Nature.

[38]  K. Entian,et al.  Mutation of a gene essential for ribosome biogenesis, EMG1, causes Bowen-Conradi syndrome. , 2009, American journal of human genetics.

[39]  M. Stark,et al.  A versatile partner of eukaryotic protein complexes that is involved in multiple biological processes: Kti11/Dph3 , 2008, Molecular microbiology.

[40]  T. Kinzy,et al.  Translation Elongation Factor 2 Anticodon Mimicry Domain Mutants Affect Fidelity and Diphtheria Toxin Resistance* , 2006, Journal of Biological Chemistry.

[41]  A. Kulkarni,et al.  Dph3, a Small Protein Required for Diphthamide Biosynthesis, Is Essential in Mouse Development , 2006, Molecular and Cellular Biology.

[42]  R. Behringer,et al.  OVCA1: tumor suppressor gene. , 2005, Current opinion in genetics & development.

[43]  G. Fink,et al.  Identification of the Proteins Required for Biosynthesis of Diphthamide, the Target of Bacterial ADP-Ribosylating Toxins on Translation Elongation Factor 2 , 2004, Molecular and Cellular Biology.

[44]  R. Behringer,et al.  Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis. , 2004, Genes & development.

[45]  K Nasmyth,et al.  Identification of Subunits of the Anaphase-Promoting Complex of Saccharomyces cerevisiae , 1996, Science.

[46]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[47]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[48]  Francesca Storici,et al.  The delitto perfetto approach to in vivo site-directed mutagenesis and chromosome rearrangements with synthetic oligonucleotides in yeast. , 2006, Methods in enzymology.

[49]  W. McLaren,et al.  Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor , 2022 .